Saturday 17 October 2026 Export CYVNY’s income statement to Excel — free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR

CYVNY Healthcare Biotechnology

Ceryvyn Therapeutics Ltd. - Unsponsored ADR’s revenue for fiscal 2025 (year ended June 2025) was $25,000.00, down 80.0% from fiscal 2024.

0.02 0.00 0.00%

Follow CYVNY

Alert me

Market cap: $524.8M
P/E: 0.0×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 3/9
Altman Z: −30.38
Beneish M: −3.64
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '23	Jun '24	Dec '24	Jun '25
ROE Full definition →	+8 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(330.64)	(420.34)	(423.62)	(461.65)
Capital Expenditures Full definition →		(0.05)	(0.07)	(0.07)	(0.06)
Other line items
Cash ROIC Full definition →		(113.63%)	(141.43%)	(227.85%)	302.47%
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates